The FDA has issued a draft guidance to simplify the procedure of developing drugs for rare pediatric disorders.
A recent study in JAMA Pediatrics found that children's hospitals had the largest financial losses when treating children covered by Medicaid.
Use of Advair (fluticasone-salmeterol; GlaxoSmithKline) combination therapy for treatment of asthma among pediatric patients demonstrated similar safety to fluticasone monotherapy in a recent clinical trial.
Differences in practice styles for the treatment of asthma among children were associated with wide variations in costs and resource utilization during hospital admissions, according to recent research.
In a cross-sectional study, researchers studied data on unplanned readmissions at the Boston Children’s Hospital within 30 days of discharge. The analysis included identifying readmissions that were potentially preventable to identify targets for quality improvement efforts.